XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Note Interest
The Mann Group L L C
Common Stock
Common Stock
Convertible Note Interest
The Mann Group L L C
Additional Paid-in Capital
Additional Paid-in Capital
Convertible Note Interest
The Mann Group L L C
Accumulated Deficit
Beginning Balance at Dec. 31, 2022 $ (250,538)   $ 2,638   $ 2,964,293   $ (3,217,469)
Beginning Balance (in shares) at Dec. 31, 2022     263,793        
Issuance of common stock associated with at-the-market placement 1,199   $ 3   1,196    
Issuance of common stock associated with at-the-market placement (in shares)     269        
Issuance costs associated with at-the- market placement (24)       (24)    
Net issuance of common stock associated with stock options and restricted stock units 52   $ 2   50    
Net issuance of common stock associated with stock options and restricted stock units (in shares)     206        
Issuance of common stock pursuant to conversion notes   $ 55       $ 55  
Issuance of common stock pursuant to conversion notes (in shares)       11      
Stock-based compensation expense 3,655       3,655    
Net loss income (9,795)           (9,795)
Ending Balance at Mar. 31, 2023 (255,396)   $ 2,643   2,969,225   (3,227,264)
Ending Balance (in shares) at Mar. 31, 2023     264,279        
Beginning Balance at Dec. 31, 2023 (246,168)   $ 2,700   2,980,539   (3,229,407)
Beginning Balance (in shares) at Dec. 31, 2023     270,034        
Issuance of common stock associated with at-the-market placement 1,361       1,361    
Issuance of common stock associated with at-the-market placement (in shares)     416        
Net issuance of common stock associated with stock options and restricted stock units 266   $ 3   263    
Net issuance of common stock associated with stock options and restricted stock units (in shares)     337        
Issuance of common stock pursuant to conversion notes   $ 56       $ 56  
Issuance of common stock pursuant to conversion notes (in shares)       15      
Stock-based compensation expense 3,885       3,885    
Net loss income 10,630           10,630
Ending Balance at Mar. 31, 2024 $ (229,970)   $ 2,703   $ 2,986,104   $ (3,218,777)
Ending Balance (in shares) at Mar. 31, 2024     270,802